Company page

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.